Printer Friendly

COMPANY INFORMATION
Med BioGene Inc. 300-2386 East Mall Vancouver, BC V6T 1Z3 Tel: (604) 827-5100 Fax: (604) 827-5120 Contact Name Erinn B. Broshko Industry Pharmaceuticals		Key Executives Erinn B. Broshko, CEO David G. Matthews, CFO Develops genomic-based clinical laboratory diagnostic and screening tests for cancer and cardiovascular diseases by identifying the genes, known as biomarkers, that indicate the presence or predict the prognosis of disease.
FP ADVISOR COVERAGE Med BioGene Inc. • FP Corporate Surveys • FP Directory of Directors • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/MBI $0.13 $0.20 $0.05 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 154,409 n.a. $-0.05 Sept. 30/09 62.5% -35.74% n.a. $8,049
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Net income (2,265) (2,449) (3,518) Total assets 1,431 2,044 889 $ $ $ Earnings per share* (0.07) (0.09) (0.20) % % % Return on equity (171.14) (259.02) n.m.   * Common

COMPANY NEWS

Results for 'Med BioGene Inc.' from past 30 days: No hits. (Links are to articles.)